EV-enriched plasma
-
not specified
Microarray; Clinical Sample Validation
elevated in EV-enriched plasma from MPC patients relative to controls
circACVR2A is detectable in EV-enriched plasma and is elevated in patients with metastatic prostate cancer compared with cancer-free controls, supporting potential as a minimally invasive biomarker. No mechanism is studied.
0.2995
The transcriptional landscape and biomarker potential of circular RNAs in prostate cancer.
combined biological and clinical study